Markers associated with testosterone enhancement of methamphetamine-induced striatal dopaminergic neurotoxicity

Neurotoxicology and Teratology

Volumn 34, Issue 3, 2012, Pages 338-343

  Buletko, A Blake ^a   Dluzen, Dean E ^a,b   McDermott, Janet L ^a   Darvesh, Altaf S ^a,b   Geldenhuys, Werner J ^b  

^a Northeast Ohio Medical University   (United States)

^b NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

Author keywords

Body temperature; Body weight; Heat Shock Protein 70 (HSP 70); Nigrostriatal dopaminergic; Progesterone; Testosterone propionate

Indexed keywords

BIOLOGICAL MARKER; DOPAMINE; DOPAMINE TRANSPORTER; HEAT SHOCK PROTEIN 70; METHAMPHETAMINE; OIL; PROGESTERONE; TESTOSTERONE PROPIONATE; VESICULAR MONOAMINE TRANSPORTER 2; SLC18A2 PROTEIN, MOUSE; VESICULAR MONOAMINE TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE MEASUREMENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOPAMINERGIC SYSTEM; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RECTUM TEMPERATURE; STRIATE CORTEX; WEIGHT REDUCTION; ANIMAL; BODY TEMPERATURE; BODY WEIGHT; CORPUS STRIATUM; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; MOUSE STRAIN; TOXICITY AND INTOXICATION; WESTERN BLOTTING; DOPAMINE BRAIN LEVEL;

MUS;

ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; BODY TEMPERATURE; BODY WEIGHT; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DRUG SYNERGISM; HSP70 HEAT-SHOCK PROTEINS; MALE; METHAMPHETAMINE; MICE; MICE, INBRED STRAINS; NEUROTOXICITY SYNDROMES; OXIDATIVE STRESS; TESTOSTERONE PROPIONATE; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 84860299391     PISSN: 08920362     EISSN: 18729738     Source Type: Journal    
DOI: 10.1016/j.ntt.2012.03.003     Document Type: Article

References (54)

1. Albers D.S., Sonsalla P.K. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents. J Pharmacol Exp Ther 1995, 275:1104-1114.
2. Anderson L.I., Leipheimer R.E., Dluzen D.E. Effects of neonatal and prepubertal hormonal manipulations upon estrogen neuroprotection of the nigrostriatal dopaminergic system within female and male mice. Neuroscience 2005, 130:369-382.
3. Bourque M., Liu B., Dluzen D.E., Di Paolo T. Sex differences in methamphetamine toxicity in mice: effect on brain dopamine signaling pathways. Psychoneuroendocrinology 2011, 36:955-969.
4. Bowyer J.F., Tank A.W., Newport G.D., Slikker W., Ali S.F., Holson R.R. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J Pharmacol Exp Ther 1992, 260:817-824.
5. Bowyer J.F., Davies D.L., Schmued L., Broening H.W., Newport G.D., Slikker W., et al. Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J Pharmacol Exp Ther 1994, 268:1571-1580.
6. Broening H.W., Pu C., Vorhees C.V. Methamphetamine selectively damages dopaminergic innervation to the nucleus accumbens core while sparing the shell. Synapse 1997, 27:153-160.
7. Broening H.W., Pu C., Vorhees C.V. Methamphetamine selectively reduces tyrosine hydroxylase immunoreactivity in the core of the nucleus accumbens while sparing the shell region. Neurotox Teratol 1996, 18:333-334.
8. Cadet J.L., Krasnova I.N., Jayanthi S., Lyles J. Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms. Neurotox Res 2007, 11:183-202.
9. Chen R., Osterhaus G., McKerchar T., Fowler S.C. The role of exogenous testosterone in cocaine-induced behavioral sensitization and plasmalemmal vesicular dopamine uptake in castrated rats. Neurosci Lett 2003, 531:161-164.
10. Daniels A.J., Reinhard J.F. Energy-driven uptake of the neurotoxin 1-methyl-4-phenylpyridinium into chromaffin granules via the catecholamine transporter. J Biol Chem 1988, 263:5034-5036.
11. D'Astous M., Gajjar T.M., Dluzen D.E., Di Paolo T. Dopamine transporter as a marker of neuroprotection in methamphetamine-lesioned mice treated acutely with estradiol. Neuroendocrinology 2004, 79:296-304.
12. D'Astous M., Mickley K.R., Dluzen D.E., Di Paolo T. Differential protective properties of estradiol and tamoxifen against methamphetamine-induced nigrostriatal dopaminergic toxicity in mice. Neuroendocrinology 2005, 82:111-120.
13. Disshon K.A., Boja J.W., Dluzen D.E. Inhibition of striatal dopamine transporter activity by 17B-estradiol. Eur J Pharmacol 1998, 345:207-211.
14. Dluzen D.E. The effect of gender and the neurotrophin, BDNF, upon methamphetamine-induced neurotoxicity of the nigrostriatal dopaminergic system in mice. Neurosci Lett 2004, 359:135-138.
15. Dluzen D.E., Anderson L.I., Pilati C.F. Methamphetamine-gonadal steroid hormonal interactions: Effects upon acute toxicity and striatal dopamine concentrations. Neurotox Teratol 2002, 24:267-273.
16. Dluzen D.E., Liu B. Gender differences in methamphetamine use and responses. Gend Med 2008, 5:24-35.
17. Dluzen D.E., McDermott J.L. Estrogen, anti-estrogen and gender differences in methamphetamine neurotoxicity. Ann N Y Acad Sci 2002, 965:135-156.
18. Dluzen D.E., McDermott J.L. Estrogen, testosterone and methamphetamine toxicity. Ann N Y Acad Sci 2006, 1074:282-294.
19. Dluzen D.E., McDermott J.L., Anderson L.I. Tamoxifen diminishes methamphetamine-induced striatal dopamine depletion in intact female and male mice. J Neuroendocrinol 2001, 13:618-624.
20. Dluzen D.E., McDermott J.L., Darvesh A.S. Relationships among gender, age, time, and temperature in methamphetamine-induced striatal dopaminergic neurotoxicity. Neuroscience 2010, 167:985-993.
21. Dluzen D.E., Salvaterra T.J. Sex differences in methamphetamine-evoked striatal dopamine output are abolished following gonadectomy: comparisons with potassium-evoked output and responses in prepubertal mice. Neuroendocrinology 2005, 82:78-86.
22. Dluzen D.E., Tweed C., Anderson L.I., Laping N.J. Gender differences in methamphetamine-induced mRNA associated with neurodegeneration in the mouse nigrostriatal dopaminergic system. Neuroendocrinology 2003, 77:232-238.
23. Erickson J.D., Eiden L.E., Hoffman B.J. Expression cloning of a reserpine-sensitive vesicular monoamine transporter. Proc Natl Acad Sci U S A 1992, 89:10993-10997.
24. Escobedo I., Peraile I., Orio L., Colado M.I., O'Shea E. Evidence for a role of Hsp70 in the neuroprotection induced by heat shock pre-treatment against 3,4-methylenedioxymethamphetamine toxicity in rat brain. J Neurochem 2007, 101:1272-1283.
25. Frye C.A., Sora I. Progesterone reduces hyperactivity of female and male dopamine transporter knockout mice. Behav Brain Res 2010, 209:59-65.
26. Gajjar T.M., Anderson L.I., Dluzen D.E. Acute effects of estrogen upon methamphetamine induced neurotoxicity of the nigrostriatal dopaminergic system. J Neural Transm 2003, 110:1215-1224.
27. Gao X., Dluzen D.E. The effect of testosterone upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system. Neuroscience 2001, 103:385-394.
28. Goto S., Korematsu K., Oyama T., Yamada K., Inoue N., Nagahiro S., et al. Neuronal induction of 72-kDa heat shock protein following methamphetamine-induced hyperthermia in the mouse hippocampus. Brain Res 1993, 626:351-356.
29. Hall J.N., Broderick P.M. Community networks for response to abuse outbreaks of methamphetamine and its analogs. NIDA Res Monogr 1991, 115:109-120.
30. Heller A., Bubla N., Lew R., Heller B., Won L. Gender dependent enhanced adult neurotoxic response to methamphetamine following fetal exposure to the drug. J Pharmacol Exp Ther 2001, 298:769-779.
31. Kitamura O. Detection of methamphetamine neurotoxicity in forensic autopsy cases. Leg Med (Tokyo) 2009, 11:S63-S65.
32. Kunnathur V., Shemisa K., Liu B., Salvaterra T.J., Dluzen D.E. Sex differences in methamphetamine-evoked striatal dopamine of mice are reversed by nomifensine. Neurotox Teratol 2006, 28:557-562.
33. Kuperman D.I., Freyaldenhoven T.E., Schued L.C., Ali S.F. Methamphetamine-induced hyperthermia in mice: examination of dopamine depletion and heat-shock protein induction. Brain Res 1997, 771:221-227.
34. Laskowska E., Matuszewska E., Kuczyńska-Wiśnik D. Small heat shock proteins and protein-misfolding diseases. Curr Pharm Biotechnol 2010, 11:146-157.
35. Lewis C., Dluzen D.E. Testosterone enhances dopamine depletion by methamphetamine in male, but not female, mice. Neurosci Lett 2008, 448:130-133.
36. Lin C.-Y., Lin M.-T., Cheng R.-T., Chen S.-H. Testosterone depletion by castration may protect mice from heat-induced multiple organ damage and lethality. J Biomed Biotechnol 2010, 10.1155/2010/485306.
37. Liu B., Dluzen D.E. Gender Differences in Methamphetamine Use and Effects: Clinical and Experimental Evidence. Drug and Alcohol Abuse Research Focus 2007, 63-88. Nova Science Publishers. T.A. Walcott (Ed.).
38. Mayer R.J., Brown I.R. Heat shock proteins in the nervous system 1994, Academic Press, San Diego.
39. Mickley K.R., Dluzen D.E. Dose-response effects of estrogen and tamoxifen upon methamphetamine-induced behavioral responses and neurotoxicity of the nigrostriatal dopaminergic system of female mice. Neuroendocrinology 2004, 79:305-316.
40. Miller D.B., Ali S.F., O'Callaghan J.P., Laws S.C. The impact of gender and estrogen on striatal dopaminergic neurotoxicity. Ann N Y Acad Sci 1998, 844:153-165.
41. Miller D.B., O'Callaghan J.P. Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse. J Pharmacol Exp Ther 1994, 270:752-760.
42. Miller D.B., O'Callaghan J.P. The role of temperature, stress and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine. Mol Neurobiol 1995, 11:177-192.
43. Moriyama Y., Amakatsu K., Futai M. Uptake of the neurotoxin, 4-methylphenylpyridinium, into chromaffin granules and synaptic vesicles: a protein gradient drives its uptake through monoamine transporter. Arch Biochem Biophys 1993, 305:271-277.
44. Rajdev S., Sharp F.R. Stress proteins as molecular markers of neurotoxicity. Toxicol Pathol 2000, 28:105-112.
45. Reinhard J.F., Diliberto E.J., Viveros O.H., Daniels A.J. Subcellular compartmentalization of 1-methyl-4-phenylpyridinium with catecholames in adrenal medullary chromaffin vesicles may explain the lack of toxicity to adrenal chromaffin cells. Proc Natl Acad Sci U S A 1987, 84:8160-8164.
46. Riddle E.L., Fleckenstein A.N., Hanson G.R. Mechanisms of methamphetamine-induced dopaminergic neurotoxicity. AAPS J 2006, 8:E413-E418.
47. Sharp F.R., Sagar S.M. Alterations in gene expression as an index of neuronal injury: Heat shock and the immediate early gene response. Neurotoxicology 1994, 15:51-59.
48. Sharp F.R., Massa S.M., Swanson R.A. Heat shock protein protection. Trends Neurosci 1999, 22:97-99.
49. Sprague J.E., Moze P., Caden D., Rusyniak D.E., Holmes C., Goldstein D.S., et al. Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3,4-methylenedioxymethamphetamine (MDMA, Ecstacy) in an animal model. Crit Care Med 2005, 33:1443-1445.
50. Wagner G.C., Tekirian T.L., Cheo C.T. Sexual differences in sensitivity to methamphetamine toxicity. J Neural Transm 1993, 93:67-70.
51. Yu L., Kuo Y., Cherng C.G., Chen H.-H., Hsu C.-H. Ovarian hormones do not attenuate methamphetamine-induced dopaminergic neurotoxicity in mice gonadectomized at 4 weeks postpartum. Neuroendocinology 2002, 75:282-287.
52. Yu L., Liao P.C. Estrogen and progesterone distinctly modulate methamphetamine-induced dopamine and serotonin depletions in C57BL/6J mice. J Neural Transm 2000, 107:1139-1147.
53. Yu L., Liao P.C. Sexual difference and estrous cycle in methamphetamine-induced dopamine and serotonin depletions in the striatum of mice. J Neural Transm 2000, 107:419-427.
54. Yu Y.L., Wagner G.C. Influence of gonadal hormones on sexual differences in sensitivity to methamphetamine-induced neurotoxicity. J Neural Transm Park Dis Dement Sect 1994, 8:215-221.